Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam +5.4% Management holding investor roadshow
  Source: Dow Jones & Co, Inc     |     Publish date: Tue, 18 Dec 13:14     |     > > Read article in News website
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap
Exercise rights is a no. But some brokers allow you to trade the rights. It depends on the broker, suggest you check with your remisier. If you are using Phillip, you wont get to trade the rights even. You need to liquidate your position before XR.
Page 3, footer point 7 - http://www.phillipcfd.com/download/PhillipCFDInfoSheet.pdf
tiancai007 ( Date: 18-Dec-2012 17:26) Posted:
By the way, using CFD cannot exercise rights and bonds right? Because physically one dont really own the shares. Correct me if I'm wrong. Tks.
In my view, this is the way it should be. It would a lousy strategy for longists to push the price all the way up in one day.
eurekaw ( Date: 18-Dec-2012 17:02) Posted:
gapping down at closing? 
New123 ( Date: 18-Dec-2012 16:54) Posted:
is a gd time to sell if u are into profit. think it will go much lower after ex.rights . seems like a dead cat bounce , dont think it will cont up trend...
Can someone help  explain what it means if one currently holds 15 lots of Olam in simple term with examples on the entitlements and the amount one has to folk out and the benefits.  Thanks
eurekaw ( Date: 18-Dec-2012 17:02) Posted:
gapping down at closing? 
New123 ( Date: 18-Dec-2012 16:54) Posted:
is a gd time to sell if u are into profit. think it will go much lower after ex.rights . seems like a dead cat bounce , dont think it will cont up trend...
is a gd time to sell if u are into profit. think it will go much lower after ex.rights . seems like a dead cat bounce , dont think it will cont up trend...
Agree. However, although this is generally the case, it is less so in Olam's case. In my view, the rights issue of bonds was designed mainly to squeeze short sellers. Therefore, for it to be effective, the return must be relatively more attractive to induce shareholders to take up their rights. Shareholders will lose out if they do not take up their rights. If the objective of the rights issue was solely to raise fund to ensure survival, Olam could have done it in the equity market.
tiancai007 ( Date: 18-Dec-2012 16:47) Posted:
The higher the yields the risker of defaulting. Hope u know the risk before exercising to buy the bonds. Looking at Greek bonds u will know. Corporate bond sld be the same is'nt it?
Richardus ( Date: 18-Dec-2012 16:28) Posted:
Thanks, counter! Appreciate your comment! How do you invest in those bonds you mentioned? (sorry i'm inexperienced with bonds). Cheers! 
Good info, indeed! Thanks for sharing and offer for contact! Gratitude!
Let me call my banker at UOB and discuss with him first :D
Cheers again!
counter ( Date: 18-Dec-2012 16:43) Posted:
I invest in bonds through Standard Chartered. Whenever there is a new issue which gives me the return that I expect, my personal banker will give me a call. IPO bonds can be purchased at around 100.025 per lot and the prices usually, but not always, rise over time. IPO bonds in Aussie dollars typically cost A$100 000 per lot. Do let me know if you are interested. I can give you the contact.
Richardus ( Date: 18-Dec-2012 16:28) Posted:
Thanks, counter! Appreciate your comment! How do you invest in those bonds you mentioned? (sorry i'm inexperienced with bonds). Cheers!